|
Day 0
|
Day 110
|
Day 168
|
Day 240
|
---|
Gradeb
|
Group A
|
Group B
|
Group C
|
Group A
|
Group B
|
Group C
|
Group A
|
Group B
|
Group C
|
Group A
|
Group B
|
Group C
|
---|
0
|
10
|
8
|
9
|
8
|
4
|
1
|
9
|
5
|
3
|
9
|
4
|
4
|
1
|
0
|
1
|
1
|
0
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
3
|
2
|
0
|
0
|
0
|
2
|
3
|
3
|
1
|
1
|
3
|
0
|
1
|
1
|
3
|
0
|
0
|
0
|
0
|
1
|
4
|
0
|
1
|
2
|
0
|
2
|
1
|
-
aTreatment groups: Group A, selamectin topical; Group B, oral ivermectin initiated on Day 70 PI; Group C, infected, untreated
-
bEosinophils as percent of nucleated cells on BAL by rank: Grade 0 < 16%, Grade 1 = 17–35%, Grade 2 = 36–60%, Grade 3 > 61%